EGFR and cancer: Further research on the therapeutic application of ESTP should translate into a novel cancer therapy characterized by modulating, in cancer cells, the activity and/or expression level of proteins that include EGFR, AKT, NOTCH, and likely protein tyrosine kinase 2 (PTK2), due to obtaining a strong integrin binding-site.